Erythema nodosum in a patient with renal cell carcinoma treated with interleukin 2 and lymphokine-activated killer cells.
D000328:Adult; D002292:Carcinoma, Renal Cell / Q000628:therapy; D004893:Erythema Nodosum / Q000209:etiology*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000628:therapy; D007694:Killer Cells, Natural / Q000276:immunology*
D007376:Interleukin-2